Oncotarget
Fusion of 3T3 or p53-/- 3T3 fibroblasts. At 6 h after fusion, the cells were fixed and centrosomes were visualized with immunostaining for γ-tubulin. The nuclei were stained with DAPI. See Chui Chui Ho et al. The requirement of p53 for maintaining chromosomal stability during tetraploidization (pp 583).
Beta-adrenergic signaling, a novel target for cancer therapy? |
https://doi.org/10.18632/oncotarget.182 Hildegard M. Schuller |
466-469 |
PDF | HTML | How to cite | Order a Reprint |
A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53 |
https://doi.org/10.18632/oncotarget.183 Robert I. Glazer |
470-471 |
PDF | HTML | How to cite | Order a Reprint |
Refractory chronic lymphocytic leukemia – new therapeutic strategies |
https://doi.org/10.18632/oncotarget.184 Andrea Schnaiter, and Stephan Stilgenbauer |
472-482 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Standards and Impact of Hematopathology in Myelodysplastic Syndromes (MDS) |
https://doi.org/10.18632/oncotarget.185 Peter Valent, Attilio Orazi, Guntram Büsche, Annette Schmitt-Gräff, Tracy I. George, Karl Sotlar, Berthold Streubel, Christine Beham-Schmid, Sabine Cerny-Reiterer, Otto Krieger, Arjan van de Loosdrecht, Wolfgang Kern, Kiyoyuki Ogata, Friedrich Wimazal, Judit Csomor, Judit Várkonyi, Wolfgang R. Sperr, Martin Werner, Hans Kreipe, and Hans-Peter Horny |
483-496 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
EGFR-mutated lung cancer: a paradigm of molecular oncology |
https://doi.org/10.18632/oncotarget.186 Zhenfeng Zhang, Amy L. Stiegler, Titus J. Boggon, Susumu Kobayashi, and Balazs Halmos |
497-514 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel future |
https://doi.org/10.18632/oncotarget.187 Karen Mulder, Sheryl Koski, Andrew Scarfe, Quincy Chu, Karen King, and Jennifer Spratlin |
515-529 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Targeting the PI3K/Akt/mTOR Pathway – Beyond Rapalogs |
https://doi.org/10.18632/oncotarget.188 Ben Markman, Rodrigo Dienstmann, and Josep Tabernero |
530-543 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
The pursuit of oncotargets through understanding defective cell regulation |
https://doi.org/10.18632/oncotarget.189 Meng Qiao, Qian Shi, and Arthur B. Pardee |
544-551 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Targeting Metabolic Remodeling in Glioblastoma Multiforme |
https://doi.org/10.18632/oncotarget.190 Amparo Wolf, Sameer Agnihotri, and Abhijit Guha |
552-562 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells |
https://doi.org/10.18632/oncotarget.191 Joshua C. Curtin, and Matthew V. Lorenzi |
563-577 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Role of dual PI3/Akt and mTOR inhibition in Waldenstrom's Macroglobulinemia |
https://doi.org/10.18632/oncotarget.192 Antonio Sacco, Aldo Roccaro, and Irene M. Ghobrial |
578-582 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
The requirement of p53 for maintaining chromosomal stability during tetraploidization |
https://doi.org/10.18632/oncotarget.193 Chui Chui Ho, Pok Man Hau, Miriam Marxer, and Randy Y.C. Poon |
583-595 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
The Class I Hdac Inhibitor Mgcd0103 Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Initiating Cells by Upregulating Dickkopf-1 and Non-Canonical Wnt Signaling |
https://doi.org/10.18632/oncotarget.194 Shaheen Sikandar, Diana Dizon, Xiling Shen, Zuomei Li, Jeffery Besterman, and Steven M. Lipkin |
596-605 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Homologous recombination repair is essential for repair of vosaroxin-induced DNA double-strand breaks |
https://doi.org/10.18632/oncotarget.195 Rachael Elizabeth Hawtin, David Elliot Stockett, Oi Kwan Wong, Cecilia Lundin, Thomas Helleday, and Judith Ann Fox |
606-619 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Sumoylation of Vimentin354 Is Associated with PIAS3 Inhibition of Glioma Cell Migration |
https://doi.org/10.18632/oncotarget.196 Liming Wang, Jian Zhang, Sipra Banerjee, Laura Barnes, Venkateswara Sajja, Yiding Liu, Baochuan Guo, Yuping Du, Mukesh K. Agarwal, David N. Wald, Qin Wang, and Jinbo Yang |
620-627 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Beta-Blocker Drug Therapy Reduces Secondary Cancer Formation in Breast Cancer and Improves Cancer Specific Survival |
https://doi.org/10.18632/oncotarget.197 Desmond G. Powe, Melanie J. Voss, Kurt S. Zänker, Hany O. Habashy, Andrew R. Green, Ian O. Ellis, and Frank Entschladen |
628-638 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy |
https://doi.org/10.18632/oncotarget.198 Bhavya Rao, Ingeborg M.M. van Leeuwen, Maureen Higgins, Johanna Campbell, Alastair M. Thompson, David P. Lane, and Sonia Lain |
639-650 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget |
https://doi.org/10.18632/oncotarget.199 Inti Zlobec, and Alessandro Lugli |
651-661 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Targeting tumor angiogenesis with TSP-1-based compounds: rational design of antiangiogenic mimetics of endogenous inhibitors |
https://doi.org/10.18632/oncotarget.200 Giulia Taraboletti, Marco Rusnati, Laura Ragona, and Giorgio Colombo |
662-673 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Wnt/Β-Catenin and Sex Hormone Signaling In Endometrial Homeostasis and Cancer |
https://doi.org/10.18632/oncotarget.201 Yongyi Wang, Marten van der Zee, Riccardo Fodde, and Leen J. Blok |
674-684 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Novel Insights into the Molecular Mechanisms Governing Mdm2 Ubiquitination and Destruction |
https://doi.org/10.18632/oncotarget.202 Hiroyuki Inuzuka, Hidefumi Fukushima, Shavali Shaik, and Wenyi Wei |
685-690 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC